RGS17 and neoplasm: By inhibiting RGS17, the balance of these signaling pathways could be shifted, potentially limiting the ability of cancer cells to proliferate and invade surrounding tissues by reducing cell division, potentially slowing down tumor growth, decreasing cell survival, and increasing apoptosis in tumor cells [66].